Related references
Note: Only part of the references are listed.Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
Matthew J. Armstrong et al.
JOURNAL OF HEPATOLOGY (2012)
Abnormal liver tests in people aged 75 and above: prevalence and association with mortality
K. M. Fleming et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The Rotterdam Study: 2012 objectives and design update
Albert Hofman et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)
Body-Mass Index and Mortality among 1.46 Million White Adults.
Amy Berrington de Gonzalez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality
Marcello Tonelli et al.
CIRCULATION (2009)
Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey
Duk-Hee Lee et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
Elevated Serum Alanine Aminotransferase and γ-Glutamyltransferase and Mortality in the United States Population
Constance E. Ruhl et al.
GASTROENTEROLOGY (2009)
The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes
S. G. Wannamethee et al.
ATHEROSCLEROSIS (2008)
Impact of fatty liver disease on health care utilization and costs in a general population: A 5-year observation
Sebastian E. Baumeister et al.
GASTROENTEROLOGY (2008)
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Janus P. Ong et al.
JOURNAL OF HEPATOLOGY (2008)
Role for alkaline phosphatase as an inducer of vascular calcification in renal failure?
M. Schoppet et al.
KIDNEY INTERNATIONAL (2008)
Gamma glutamyltransferase and long-term survival: Is it just the liver?
Lili Kazemi-Shirazi et al.
CLINICAL CHEMISTRY (2007)
Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study
Roger K. Schindhelm et al.
ATHEROSCLEROSIS (2007)
Low alanine aminotransferase activity in older people is associated with greater long-term mortality
Eran Elinav et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States
GN Ioannou et al.
HEPATOLOGY (2006)
γ-glutamyltransferase as a risk factor for cardiovascular disease mortality -: An epidemiological investigation in a cohort of 163,944 Austrian adults
E Ruttmann et al.
CIRCULATION (2005)
Correlation between serum alanine aminotransferase activity and age: An inverted U curve pattern
E Elinav et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
HC Kim et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Effect of age and hypoxia/reoxygenation on mRNA expression of antioxidative enzymes in rat liver and kidneys
R Martin et al.
EXPERIMENTAL GERONTOLOGY (2002)
AGA technical review on the evaluation of liver chemistry tests
RM Green et al.
GASTROENTEROLOGY (2002)
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati et al.
ANNALS OF INTERNAL MEDICINE (2002)
Ethnic-immigrant differentials in health behaviors, morbidity, and cause-specific mortality in the United States: An analysis of two national data bases
GK Singh et al.
HUMAN BIOLOGY (2002)
Primary care: Evaluation of abnormal liver-enzyme results in asymptomatic patients.
DS Pratt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)